300238 Stock Overview
Develops, manufactures, and sells regenerative medicines and life sciences products primarily in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Guanhao Biotech Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥10.50 |
| 52 Week High | CN¥15.88 |
| 52 Week Low | CN¥7.48 |
| Beta | 0.65 |
| 11 Month Change | 13.51% |
| 3 Month Change | 10.64% |
| 1 Year Change | -21.05% |
| 33 Year Change | -43.43% |
| 5 Year Change | -58.28% |
| Change since IPO | -6.48% |
Recent News & Updates
Optimistic Investors Push Guanhao Biotech Co.,Ltd. (SZSE:300238) Shares Up 28% But Growth Is Lacking
Sep 02
Guanhao Biotech Co.,Ltd. (SZSE:300238) May Have Run Too Fast Too Soon With Recent 28% Price Plummet
Jun 07Guanhao Biotech Co.,Ltd.'s (SZSE:300238) 26% Share Price Plunge Could Signal Some Risk
Apr 23Recent updates
Optimistic Investors Push Guanhao Biotech Co.,Ltd. (SZSE:300238) Shares Up 28% But Growth Is Lacking
Sep 02Guanhao Biotech Co.,Ltd. (SZSE:300238) May Have Run Too Fast Too Soon With Recent 28% Price Plummet
Jun 07Guanhao Biotech Co.,Ltd.'s (SZSE:300238) 26% Share Price Plunge Could Signal Some Risk
Apr 23Guanhao Biotech Co.,Ltd.'s (SZSE:300238) 32% Share Price Surge Not Quite Adding Up
Mar 09Shareholder Returns
| 300238 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 22.0% | 0.4% | -0.6% |
| 1Y | -21.1% | -24.5% | -21.3% |
Return vs Industry: 300238 exceeded the CN Biotechs industry which returned -24.5% over the past year.
Return vs Market: 300238 matched the CN Market which returned -21.3% over the past year.
Price Volatility
| 300238 volatility | |
|---|---|
| 300238 Average Weekly Movement | 8.3% |
| Biotechs Industry Average Movement | 6.0% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 8.9% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 300238 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300238's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 535 | Yongming Zhang | www.guanhaobio.com |
Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products primarily in China. It offers NormalGEN, a dura repair patch; GrandNeuro, a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses.
Guanhao Biotech Co.,Ltd. Fundamentals Summary
| 300238 fundamental statistics | |
|---|---|
| Market cap | CN¥2.78b |
| Earnings (TTM) | CN¥20.41m |
| Revenue (TTM) | CN¥383.06m |
136.4x
P/E Ratio7.3x
P/S RatioIs 300238 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300238 income statement (TTM) | |
|---|---|
| Revenue | CN¥383.06m |
| Cost of Revenue | CN¥85.47m |
| Gross Profit | CN¥297.60m |
| Other Expenses | CN¥277.19m |
| Earnings | CN¥20.41m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.077 |
| Gross Margin | 77.69% |
| Net Profit Margin | 5.33% |
| Debt/Equity Ratio | 16.0% |
How did 300238 perform over the long term?
See historical performance and comparison